Percutaneous Implantation of a Second Device in Patients with Residual Right‐to‐Left Shunt after Patent Foramen Ovale Closure

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Percutaneous Implantation of a Second Device in Patients with Residual Right‐to‐Left Shunt after Patent Foramen Ovale Closure

Abstract: A second percutaneous PFO occlusion device can be safely implanted in patients with significant rRLS. However, a moderate-to-large rRLS on TCD and/or TEE may not necessarily represent a significant risk of further paradoxical embolization.

Cited by 3 publications

References 34 publications

Recurrent vertebrobasilar strokes and transient-ischemic attacks with challenging workup: Case report

Recurrent vertebrobasilar strokes and transient-ischemic attacks with challenging workup: Case report

Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale

European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

Contact Info

Product

Resources

About